Respironics California, Inc., a Philips Healthcare business, today announced that the company’s worldwide recall of approximately 19,200 Philips Respironics V60 Ventilators has been designated a Class I recall by the U.S. Food and Drug Administration (FDA). On June 4, Respironics initiated a voluntary recall to correct a software issue that may cause the V60 ventilator device to shut down.

Read More...

This notice provided by Budget101.com